Globalization in Biotechnology, Ernst & Young report (cont)

As promised here is the post on globalization, one of the three major trends driving the biotechnology industry to reinvent itself, according to Ernst and Young 2008 biotechnology report. Pharma and biotech companies are taking advantage of the ‘flattenning world,’ as described by Colin Powel in his keynote speech, and jumping into the globalization trend [...]

Ernst & Young 2008 Global biotechnology report highlights

The Bio International Convention hosted a fantastic panel today on the 2008 Ernst & Young global biotechnology report.  The industry is at “the start of a revolution” and aiming to reinvent itself because of three trends, shared moderator Glen Giovannetti of Ernst & Young, (1) R&D productivity, (2) personalized medicine, and (3) globalization.  This post [...]